Read + Share
Stein EM, Fathi AT, Harb WA, Colak G, et al. Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and
tolerability of pelabresib in patients with myeloid malignancies. Leuk Lymphoma 2024;65:503-510.
PMID: 38259250
|
 |
|
Stein EM, Fathi AT, Harb WA, Colak G, et al. Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and
tolerability of pelabresib in patients with myeloid malignancies. Leuk Lymphoma 2024;65:503-510.
PMID: 38259250
|
|
|
|